The Role of Fractional Vascular Laser Therapy in the Management of Burn Scars
Launched by UNIVERSITY OF MANITOBA · Jun 12, 2012
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a special type of laser treatment called fractional vascular laser therapy on burn scars. The goal is to see if this treatment can improve the height, texture, color, and flexibility of scars that are at least six months old. While some earlier studies suggest that laser therapy might help with burn scars, more research is needed to really understand its effectiveness, especially since it can be costly compared to other treatments.
To participate in the trial, you need to be living in Winnipeg and have a thermal burn scar that is between six to twelve months old. Eligible participants should have skin types I to III and the scars must be located on the trunk or limbs. Unfortunately, if you have an open wound, you won't be able to join. If you decide to participate, you can expect to receive the laser treatment and help researchers learn more about how it can help improve burn scars. This study is currently looking for volunteers, so if you’re interested, it could be a great opportunity to contribute to important medical research.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • living in Winnipeg
- • burn scar 6-12 months old
- • Fitzpatrick skin type I-III
- • thermal burn scar on trunk or extremities
- Exclusion Criteria:
- • open wound
About University Of Manitoba
The University of Manitoba, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive expertise in medical research, public health, and community engagement to conduct rigorous and ethical clinical studies. The institution aims to translate scientific findings into practical applications that enhance patient care and improve health outcomes. Committed to fostering a culture of excellence and integrity, the University of Manitoba prioritizes participant safety and scientific validity in all its clinical research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Winnipeg, Manitoba, Canada
Patients applied
Trial Officials
S Logsetty, MD
Principal Investigator
University of Manitoba
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials